Instil Bio, Inc. TIL
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -71.37M | -75.08M | -84.51M |
| Total Depreciation and Amortization | -- | -- | 534.00K | 1.26M | 2.15M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 34.78M | 38.47M | 47.51M |
| Change in Net Operating Assets | -- | -- | -560.00K | -4.76M | -14.83M |
| Cash from Operations | -- | -- | -36.62M | -40.10M | -49.68M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 432.00K | 743.00K | 743.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 25.04M | 29.92M | 41.28M |
| Cash from Investing | -- | -- | 25.48M | 30.66M | 42.03M |
| Total Debt Issued | -- | -- | -- | 85.60M | 85.60M |
| Total Debt Repaid | -- | -- | -- | -82.84M | -82.84M |
| Issuance of Common Stock | -- | -- | 7.76M | 7.97M | 7.75M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -472.00K | -1.84M | -1.84M |
| Cash from Financing | -- | -- | 7.29M | 8.89M | 8.67M |
| Foreign Exchange rate Adjustments | -- | -- | 20.00K | -26.00K | 41.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -3.83M | -582.00K | 1.06M |